Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | FPR2 | P25090 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 2/20 | 0.42 |
| ▸ | ACE | P12821 | 2/20 | 0.42 |
| ▸ | CPA1 | P15085 | 2/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL203222 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL2034664 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL2034259 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL43380 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL43381 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL18560091 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL288609 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL17113018 | 0.98 | ALDH1A1 (0.57) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL17113020 | 0.98 | ALDH1A1 (0.57) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL12611984 | 0.92 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1FPR2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1967 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4686725-A1 | AMYLOID INHIBITORY PEPTIDES | Technische Universität München, in Vertretung des Freistaats Bayern (DE) | 2026-02-04 | — | — | EP | claimed |
| US-11891456-B2 | Amyloid inhibitory peptides | Technische Universität München (DE) | 2024-02-06 | — | — | US | claimed |
| US-20230095144-A1 | AMYLOID INHIBITORY PEPTIDES | Technische Universität München (DE) | 2023-03-30 | — | — | US | claimed |
| US-11498943-B2 | Amyloid inhibitory peptides | Technische Universität München (DE) | 2022-11-15 | — | — | US | claimed |
| US-20210340180-A1 | AMYLOID INHIBITORY PEPTIDES | Technische Universität München (DE) | 2021-11-04 | — | — | US | claimed |
| EP-3774846-A1 | AMYLOID INHIBITORY PEPTIDES | Technische Universität München (DE) | 2021-02-17 | — | — | EP | claimed |
| WO-2019234157-A1 | AMYLOID INHIBITORY PEPTIDES | Technische Universität München (DE) | 2019-12-12 | — | — | WO | claimed |
| US-9695191-B2 | Conformationally constrained, fully synthetic macrocyclic compounds | POLYPHOR AG (CH) | 2017-07-04 | — | — | US | claimed |
| EP-2462147-B1 | CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS | POLYPHOR AG (CH) | 2014-11-12 | — | — | EP | claimed |
| US-20120202821-A1 | CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS | POLYPHOR AG (CH) | 2012-08-09 | — | — | US | claimed |
| US-20100076015-A1 | Aminopyridine Derivatives | VANTIA LIMITED (GB) | 2010-03-25 | — | — | US | claimed |
| WO-2009133348-A1 | AMINOPYRIDINE DERIVATIVES | VANTIA LIMITED (GB) | 2009-11-05 | — | — | WO | claimed |
| US-20090215895-A1 | Therapeutic and carrier molecules | PEPLIN BIOLIPIDS PTY LTD (AU) | 2009-08-27 | — | — | US | claimed |
| EP-1718602-A4 | THERAPEUTIC AND CARRIER MOLECULES | PEPLIN BIOLIPIDS PTY LTD (AU) | 2007-12-12 | — | — | EP | claimed |
| US-7256172-B1 | Method of treatment and agents useful for same | THE UNIVERSITY OF MELBOURNE (AU) | 2007-08-14 | — | — | US | claimed |
| EP-1718602-A1 | THERAPEUTIC AND CARRIER MOLECULES | Peplin Biolipids Pty Ltd. (AU) | 2006-11-08 | — | — | EP | claimed |
| WO-2005073164-A1 | THERAPEUTIC AND CARRIER MOLECULES | PEPLIN BIOLIPIDS PTY LTD (AU) | 2005-08-11 | — | — | WO | claimed |
| US-20260140060-A1 | COLORIMETRIC DETECTION OF A VIRAL INFECTION | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2026-05-21 | — | — | US | disclosed |
| WO-1994011388-A1 | SUPPORT FOR THE SYNTHESIS OF MODULAR POLYMERS | CHIRON MIMOTOPES PTY. LTD. (AU) | 1994-05-26 | — | — | WO | disclosed |
| WO-1994003483-A1 | ENDOTHELIN RECEPTOR-BINDING COMPOUNDS | CHIRON CORPORATION (US) | 1994-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215895-A1 | Therapeutic and carrier molecules | PHKG1, PHKG2, DGKB | ALDH1A1 3631/4885L3MBTL1 4018/4885FPR2 352/4885 |
| US-20100076015-A1 | Aminopyridine Derivatives | CHRM1, ARG1, ARG2 | ALDH1A1 147/4885L3MBTL1 4240/4885FPR2 166/4885 |
| US-20120202821-A1 | CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS | HTR2B, MC1R, HTR1A | ALDH1A1 4268/4885L3MBTL1 3373/4885FPR2 175/4885 |
| US-20230095144-A1 | AMYLOID INHIBITORY PEPTIDES | IAPP, APP, APBA1 | ALDH1A1 4614/4885L3MBTL1 3652/4885FPR2 209/4885 |
| US-11891456-B2 | Amyloid inhibitory peptides | IAPP, APP, APBA1 | ALDH1A1 4614/4885L3MBTL1 3652/4885FPR2 209/4885 |
| US-11498943-B2 | Amyloid inhibitory peptides | IAPP, APP, APBA1 | ALDH1A1 4614/4885L3MBTL1 3652/4885FPR2 209/4885 |
| US-20260140060-A1 | COLORIMETRIC DETECTION OF A VIRAL INFECTION | CTSL, CPA4, ACE2 | ALDH1A1 1754/4885L3MBTL1 4330/4885FPR2 262/4885 |
| US-20210340180-A1 | AMYLOID INHIBITORY PEPTIDES | IAPP, APP, APBA1 | ALDH1A1 4614/4885L3MBTL1 3652/4885FPR2 209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.